Mr. Keon, where are generics in the biologics? In the recombinant DNA therapies and treatments, are the generics able to step into this space, or is this really not the generic companies' purview?
September 22nd, 2016 / 9:45 a.m.
Liberal
John Oliver Liberal Oakville, ON
Mr. Keon, where are generics in the biologics? In the recombinant DNA therapies and treatments, are the generics able to step into this space, or is this really not the generic companies' purview?
See context to find out what was said next.